Tower Research Capital LLC (Trc) Novan, Inc. Transaction History

Tower Research Capital LLC (Trc)

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.41 - $1.4 $4,177 - $14,264	10,189 Added 117.24%	18,880 $8,000
Q1 2023 May 09, 2023	SELL	$1.05 - $2.04 $6,351 - $12,339	-6,049 Reduced 41.04%	8,691 $11,000
Q4 2022 Feb 10, 2023	BUY	$0.82 - $1.48 $1,820 - $3,285	2,220 Added 17.73%	14,740 $21,000
Q3 2022 Nov 10, 2022	BUY	$1.76 - $3.03 $19,907 - $34,272	11,311 Added 935.57%	12,520 $23,000
Q2 2022 Aug 15, 2022	SELL	$2.29 - $3.86 $4,160 - $7,013	-1,817 Reduced 60.05%	1,209 $3,000
Q1 2022 May 12, 2022	BUY	$2.95 - $4.41 $1,604 - $2,399	544 Added 21.92%	3,026 $12,000
Q4 2021 Feb 14, 2022	SELL	$4.03 - $8.15 $23,724 - $47,979	-5,887 Reduced 70.34%	2,482 $11,000
Q3 2021 Nov 15, 2021	BUY	$7.48 - $10.17 $62,600 - $85,112	8,369 New	8,369 $68,000

Ticker NOVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,281,600
Market Cap $638K
Description
Novan, Inc., a pre-commercial nitric oxide-based pharmaceutical company, focuses on dermatology and anti-infective therapies. Its clinical stage dermatology drug candidates include SB204, a topical monotherapy for the treatment of acne vulgaris; SB206, a topical anti-viral gel for the treatment of viral skin infections; SB208, a topical broad-sp...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.